[go: up one dir, main page]

NO994049D0 - Metode for å fremstille farmasöytiske forbindelser - Google Patents

Metode for å fremstille farmasöytiske forbindelser

Info

Publication number
NO994049D0
NO994049D0 NO994049A NO994049A NO994049D0 NO 994049 D0 NO994049 D0 NO 994049D0 NO 994049 A NO994049 A NO 994049A NO 994049 A NO994049 A NO 994049A NO 994049 D0 NO994049 D0 NO 994049D0
Authority
NO
Norway
Prior art keywords
pharmaceutical compounds
preparing pharmaceutical
preparing
compounds
pharmaceutical
Prior art date
Application number
NO994049A
Other languages
English (en)
Other versions
NO994049L (no
Inventor
David W Hoard
Eric D Moher
Vinod Francis Patel
Original Assignee
Lilly Co Eli
Univ Hawaii
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Univ Hawaii, Univ Wayne State filed Critical Lilly Co Eli
Publication of NO994049D0 publication Critical patent/NO994049D0/no
Publication of NO994049L publication Critical patent/NO994049L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/46Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO994049A 1997-02-26 1999-08-23 Metode for aa fremstille farmasöytiske forbindelser NO994049L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3911697P 1997-02-26 1997-02-26
US3911497P 1997-02-26 1997-02-26
PCT/US1998/003655 WO1998038158A1 (en) 1997-02-26 1998-02-25 Process for preparing pharmaceutical compounds

Publications (2)

Publication Number Publication Date
NO994049D0 true NO994049D0 (no) 1999-08-23
NO994049L NO994049L (no) 1999-08-23

Family

ID=26715826

Family Applications (2)

Application Number Title Priority Date Filing Date
NO994049A NO994049L (no) 1997-02-26 1999-08-23 Metode for aa fremstille farmasöytiske forbindelser
NO994083A NO994083L (no) 1997-02-26 1999-08-24 Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO994083A NO994083L (no) 1997-02-26 1999-08-24 Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser

Country Status (17)

Country Link
US (1) US6143909A (no)
EP (2) EP0861838A3 (no)
JP (2) JP2002512603A (no)
KR (2) KR20000075623A (no)
CN (2) CN1252788A (no)
AU (2) AU738999B2 (no)
BR (2) BR9811252A (no)
CA (2) CA2281104A1 (no)
CZ (1) CZ9902998A3 (no)
EA (2) EA199900770A1 (no)
ID (2) ID24527A (no)
IL (2) IL131205A0 (no)
NO (2) NO994049L (no)
NZ (1) NZ336918A (no)
PL (2) PL335478A1 (no)
TR (2) TR199902065T2 (no)
WO (2) WO1998038158A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977387A (en) * 1996-08-30 1999-11-02 Eli Lilly And Company Process for preparing pharmaceutical compounds
AU4253997A (en) * 1996-09-06 1998-03-26 Eli Lilly And Company Process and novel intermediates
IL142565A0 (en) * 1998-10-16 2002-03-10 Lilly Co Eli Stereoselective process for producing antineoplastic agents
AU1930100A (en) * 1998-12-07 2000-06-26 Eli Lilly And Company Crotylboration process to produce cryptophycin compounds
WO2000034253A2 (en) * 1998-12-07 2000-06-15 Eli Lilly And Company Intermediates and reaction sequence to produce said intermediates useful for the preparation of antineoplastic and antifungal cryptophycin derivatives
EP1229934B1 (en) 1999-10-01 2014-03-05 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
EP1751279A4 (en) * 2004-05-05 2008-03-19 Univ Minnesota NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PREPARATION OF CRYPTOPHYCIN
CN101962323B (zh) * 2010-07-16 2013-06-05 中国人民解放军第二军医大学 2-丙烯酰x基-3-取代苯基丙酸类化合物及其用途
CN111333560B (zh) * 2020-04-13 2024-01-23 合肥工业大学 一种制备螺环β-内酰胺的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946835A (en) * 1988-07-15 1990-08-07 Merck & Co., Inc. Antifungal fermentation product and method
US4868208A (en) * 1988-07-15 1989-09-19 Merck & Co., Inc. Antifungal agent and method
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
JPH04504416A (ja) * 1989-02-17 1992-08-06 コセルコ・ミモトープス・ピィ・ティ・ワイ.エル・ティ・ディ. ペプチドの使用方法と合成方法
US5256802A (en) * 1990-04-03 1993-10-26 Miles Inc. Process for the production of oxiranes
EP0672049A4 (en) * 1992-11-06 1997-10-15 Chiron Mimotopes Pty Ltd SUPPORT FOR THE SYNTHESIS OF MODULE POLYMERS.
GB2282384B8 (en) * 1993-08-18 1997-09-04 Europ Economic Community Drug delivery agents incorporating mitomycin
US5952298A (en) * 1993-12-21 1999-09-14 The University Of Hawaii Cryptophycins
CA2179490A1 (en) * 1993-12-21 1995-06-29 Trimurtulu Golakoti New cryptophycins
CA2202480A1 (en) * 1994-10-14 1996-04-25 Jane Charlotte Moores Porphyrin labeling of polynucleotides
JP4181632B2 (ja) * 1995-03-07 2008-11-19 ユニバーシティ オブ ハワイ 新規合成クリプトフィシン類
US5843992A (en) * 1995-03-31 1998-12-01 Nippon Chemiphar Co., Ltd. Epoxysuccinic acid derivatives
US5700826A (en) * 1995-06-07 1997-12-23 Ontogen Corporation 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance
WO1997008334A1 (en) * 1995-08-30 1997-03-06 University Of Hawaii Cryptophycins from aberrant biosynthesis
JP2000502351A (ja) * 1995-12-22 2000-02-29 イーライ・リリー・アンド・カンパニー 医薬化合物
AU724312B2 (en) * 1996-02-07 2000-09-14 Buckman Laboratories International, Inc. Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
ATE201018T1 (de) * 1996-02-27 2001-05-15 Lilly Co Eli Cryptophycinderivate und ihre verwendung als antimikrotubuli mittel
CA2263420A1 (en) * 1996-08-30 1998-03-05 James Edward Ray Pharmaceutical compounds
IL128610A (en) * 1996-08-30 2004-07-25 Lilly Co Eli Cryptophycin compound and its use as a medicament for treating neoplasm
AU4169897A (en) * 1996-08-30 1998-03-19 Eli Lilly And Company Pharmaceutical compounds
US6025506A (en) * 1997-02-21 2000-02-15 Dsm N.V. Process for preparing an optically active phenylglycidyl acid derivative
TW438787B (en) * 1997-02-27 2001-06-07 Tanabe Seiyaku Co Process for preparing optically active trans-3-substituted glycidic acid ester

Also Published As

Publication number Publication date
ID22984A (id) 1999-12-23
ID24527A (id) 2000-07-20
WO1998038164A1 (en) 1998-09-03
EA002547B1 (ru) 2002-06-27
AU6667298A (en) 1998-09-18
IL131162A0 (en) 2001-01-28
NO994083D0 (no) 1999-08-24
EP0861838A2 (en) 1998-09-02
CA2281108A1 (en) 1998-09-03
EP0861838A3 (en) 1998-12-09
AU6667198A (en) 1998-09-18
NO994083L (no) 1999-10-25
PL335347A1 (en) 2000-04-25
NO994049L (no) 1999-08-23
CA2281104A1 (en) 1998-09-03
US6143909A (en) 2000-11-07
CN1252788A (zh) 2000-05-10
JP2002513403A (ja) 2002-05-08
EP0861839A1 (en) 1998-09-02
CZ9902998A3 (cs) 2002-10-16
JP2002512603A (ja) 2002-04-23
BR9807265A (pt) 2000-05-23
WO1998038158A1 (en) 1998-09-03
AU738999B2 (en) 2001-10-04
EA199900770A1 (ru) 2000-04-24
BR9811252A (pt) 2000-09-26
TR199902064T2 (xx) 2001-10-22
PL335478A1 (en) 2000-04-25
NZ336918A (en) 2001-11-30
TR199902065T2 (xx) 2000-02-21
KR20000075671A (ko) 2000-12-26
KR20000075623A (ko) 2000-12-26
CN1255121A (zh) 2000-05-31
IL131205A0 (en) 2001-01-28
EA199900772A1 (ru) 2000-04-24

Similar Documents

Publication Publication Date Title
FI973518A0 (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
NO994757L (no) Fremgangsmåte for oral administrasjon av proteiner
NO995681D0 (no) Fremgangsmåte for å fremstille fluorbiprofen-tabletter
AR017655A1 (es) Metodo para preparar eteres de monofluormetilo
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
NO20001728D0 (no) Fremgangsmåte for fremstilling av chirale forbindelser
IT1272922B (it) Procedimento per la preparazione di composti metallocenici
ID28601A (id) Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
ID22840A (id) Proses untuk penyiapan komposisi aspal
NO994049D0 (no) Metode for å fremstille farmasöytiske forbindelser
NO995851D0 (no) Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
EE9800195A (et) Uudsed analgeetilise toimega ühendid
NO20001777D0 (no) Fremgangsmåte for fremstilling av substituerte 4-fenyl-4- cyanocykloheksankarboksylsyrer
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
FI964410A7 (fi) Menetelmä 4-amino-delta4-3-ketosteroidien valmistamiseksi 4-nitro-delt a4-3-ketosteroidien kautta
ID22430A (id) Proses pembuatan senyawa-senyawa benzotiazolona
NO993863D0 (no) Forbindelser og fremgangsmåte for fremstilling av substituerte 4-fenyl-4-cyanocycloheksansyrer
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
FI950307L (fi) Menetelmä bisyklopentadienyyliyhdisteiden valmistamiseksi
EG21226A (en) Process for preparing of new pharmaceutical compound

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application